DAY ONE BIOPHARMACEUTICALS, INC. — Net Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/3fabc737-9242-46a5-9725-07bb55fd3ae6/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-107.3M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-066956 |
| FY 2024 | $-95.5M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-026654 |
| FY 2023 | $-188.9M | 2023-01-01 – 2023-12-31 | evidence 0000950170-25-026654 |
| FY 2022 | $-142.2M | 2022-01-01 – 2022-12-31 | evidence 0000950170-25-026654 |
| FY 2021 | $-72.8B | 2021-01-01 – 2021-12-31 | evidence 0001193125-26-161471 |
| FY 2020 | $-40.5M | 2020-01-01 – 2020-12-31 | evidence 0000950170-22-002959 |
| FY 2019 | $-12.6M | 2019-01-01 – 2019-12-31 | evidence 0000950170-22-002959 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
DAY ONE BIOPHARMACEUTICALS, INC. — all facts · Revenue · Operating Income